Latest filing published 03 Mar 2026 for CVRx, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin Hykes has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Hansen Medical Inc and CVRx, Inc. We count 12 filings; the first trade dates from 13 May 2013 and the latest from 2 March 2026.
On the open market, the record shows 4 purchases worth €287k and 1 sale worth €52k. Netting one side against the other leaves €235k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 1 sale.
A typical purchase (the median) is worth €24k.
Most recently, on 3 March 2026, the filings show an open-market sale worth €52k in CVRx, Inc. The last purchase on record was published on 12 May 2025, which is 530 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations